CONSOLIDATED SCHEDULE OF INVESTMENTS - Narrative (Parentheticals) - USD ($) $ in Thousands				3 Months Ended		12 Months Ended
		Sep. 30, 2024	Dec. 31, 2023	Mar. 31, 2025		Dec. 31, 2024
Percentage of net assets	[1],[2]					136.44%
Total portfolio company investments	[3]			$ 346,824	[4],[5]	$ 359,897	[1],[6]
Gross unrealized gains for tax purposes				17,300		16,400
Gross unrealized losses for tax purposes				39,900		29,300
Net unrealized losses for tax purposes				22,700		12,900
Tax cost of investments				369,900		372,800
Cost	[3]			369,526	[4],[5],[7]	372,310	[1],[6],[8]
Unrealized Gain/(Loss)				$ (349)		$ 423
Non-qualifying assets percentage				9.70%		9.50%
Total Portfolio Companies
Percentage of net assets				136.12%	[3],[4],[5],[9]	136.40%
Total portfolio company investments				$ 346,800		$ 359,900
Debt Investments
Cost of non-accrual investments				40,800		28,400
Fair value of non-accrual investments				$ 19,000		$ 16,500
Debt investments with floating interest rates | Minimum
Interest rate floor				3.25%		3.25%
Debt investments with floating interest rates | Investment Owned, Balance, Principal Amount | Interest Rate Type Risk
Outstanding Principal				$ 274,300		$ 278,400
Concentration risk percentage		82.30%	82.50%

[1] Non-income producing investments.

[2] Value as a percentage of net assets.

[3] All investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors (the “Board”).

[4] Non-income producing investments.

[5] The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Unless otherwise indicated, all of the Company’s portfolio company investments are subject to restrictions on sales. As of March 31, 2025, the Company’s portfolio company investments that were subject to restrictions on sales totaled $346.8 million at fair value and represented 136.1% of the Company’s net assets. In addition, unless otherwise indicated, as of March 31, 2025, all investments are pledged as collateral as part of the Company’s revolving credit facility.

[6] The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. Unless otherwise indicated, all of the Company’s portfolio company investments are subject to restrictions on sales. As of December 31, 2024, the Company’s portfolio company investments that were subject to restrictions on sales totaled $359.9 million at fair value and represented 136.4% of the Company’s net assets. In addition, unless otherwise indicated, as of December 31, 2024, all investments are pledged as collateral as part of the Company’s revolving credit facility.

[7] Gross unrealized gains, gross unrealized losses, and net unrealized losses for federal income tax purposes totaled $17.3 million, $39.9 million and $22.7 million, respectively, for the March 31, 2025 investment portfolio. The tax cost of investments is $369.9 million.

[8] Gross unrealized gains, gross unrealized losses, and net unrealized losses for federal income tax purposes totaled $16.4 million, $29.3 million and $12.9 million, respectively, for the December 31, 2024 investment portfolio. The tax cost of investments is $372.8 million.

[9] Value as a percentage of net assets.